Session reveals AI enhances diagnostic accuracy and understanding of inflammatory memory in psoriatic diseases.
The "hot topics" session of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting and trainee symposium explored the integration of artificial intelligence (AI) in managing psoriatic diseases (PsD) and the underlying mechanisms of inflammatory memory that drive recurrence in psoriasis and psoriatic arthritis. Drs. April Armstrong and Denis Poddubnyy discussed the transformative role of AI in enhancing diagnostic accuracy, assessing disease severity, and predicting treatment responses, particularly through deep learning models such as convolutional neural networks. AI systems have shown promise in providing objective, standardized assessments for psoriasis, with applications expanding across dermatology and rheumatology. Dr. Liv Eidsmo presented insights into inflammatory memory, a phenomenon sustained by both immune and nonimmune cells, including tissue-resident memory cells and epigenetically altered keratinocytes. Eidsmo emphasized the importance of understanding the cellular and molecular pathways that contribute to disease persistence. Both AI and inflammatory memory highlight key challenges and opportunities in PsD management; future research is needed to integrate technological advancements, with a deeper understanding of the biological processes affecting treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Shucheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: